Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harris A Ahmad

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Gastro Hep Advances|August 12, 2024
Poor Patient-Reported Outcomes and Impaired Work Productivity in Patients With Inflammatory Bowel Disease in RemissionRaymond K Cross, Jenny S Sauk, Joe Zhuo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2024
Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced TherapiesBruce E Sands, Geert D'Haens, Remo Panaccione, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 1, 2023
Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension AnalysesAlessandro Armuzzi, Raymond K Cross, Gary R Lichtenstein, et al.
The American Journal of Gastroenterology|January 8, 2025
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical TrialBruce E Sands, David T Rubin, Edward V Loftus, et al.
Journal of Crohn'S & Colitis|February 4, 2023
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential SolutionsMathieu Uzzan, Yoram Bouhnik, Maria Abreu, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Gastro Hep Advances|August 12, 2024
Poor Patient-Reported Outcomes and Impaired Work Productivity in Patients With Inflammatory Bowel Disease in RemissionRaymond K Cross, Jenny S Sauk, Joe Zhuo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 9, 2024
Ozanimod in Patients With Moderate to Severe Ulcerative Colitis Naive to Advanced TherapiesBruce E Sands, Geert D'Haens, Remo Panaccione, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 1, 2023
Cardiovascular Safety of Ozanimod in Patients With Ulcerative Colitis: True North and Open-Label Extension AnalysesAlessandro Armuzzi, Raymond K Cross, Gary R Lichtenstein, et al.
The American Journal of Gastroenterology|January 8, 2025
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical TrialBruce E Sands, David T Rubin, Edward V Loftus, et al.
Journal of Crohn'S & Colitis|February 4, 2023
Declining Enrolment and Other Challenges in IBD Clinical Trials: Causes and Potential SolutionsMathieu Uzzan, Yoram Bouhnik, Maria Abreu, et al.
Pageof 3